Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tramer, M. R.
Right arrow Articles by Fuchs-Buder, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tramer, M. R.
Right arrow Articles by Fuchs-Buder, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 82, Issue 3 379-386, Copyright © 1999 by The Board of Management and Trustees of the British Journal of Anaesthesia


CLINICAL INVESTIGATIONS

Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review

M. R. Tramer and T. Fuchs-Buder
Divison of Anaesthesiology, Department APSIC, Geneva University Hospital, CH-1211 Geneva 14, Switzerland; Department of Anaesthesiology, University of Saarland, D-66421 Homburg/Saar, Germany

We have estimated the effect of omitting antagonism of neuromuscular block on postoperative nausea and vomiting. A systematic search (MEDLINE, EMBASE, Biological Abstracts, Cochrane library, reference lists and hand searching; no language restriction, up to March 1998) was performed for relevant randomized controlled trials. In eight studies (1134 patients), antagonism with neostigmine or edrophonium was compared with spontaneous recovery after general anesthesia with pancuronium, vecuronium, mivacurium or tubocurarine. On combining neostigmine data, there was no evidence of an antiemetic effect when it was omitted. However, the highest incidence of emesis with neostigmine 1.5 mg was lower than the lowest incidence of emesis with 2.5 mg. Numbers-needed-to-treat to prevent emesis by omitting neostigmine compared with using it were consistently negative with 1.5 mg, and consistently positive (3-6) with 2.5 mg. There was a lack of evidence for edrophonium. In two studies, three patients with spontaneous recovery after mivacurium or vecuronium needed rescue anticholinesterase drugs because of clinically relevant muscle weakness (number-needed-to-harm, 30). Omitting neostigmine may have a clinically relevant antiemetic effect when high doses are used. Omitting antagonism, however, introduces a non-negligent risk of residual paralysis even with short-acting neuromuscular blocking agents.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. Srivastava and J. M. Hunter
Reversal of neuromuscular block
Br. J. Anaesth., July 1, 2009; 103(1): 115 - 129.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Eikermann, S. Zaremba, A. Malhotra, A. S. Jordan, C. Rosow, and N. L. Chamberlin
Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing
Br. J. Anaesth., September 1, 2008; 101(3): 344 - 349.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. J. Gan, T. A. Meyer, C. C. Apfel, F. Chung, P. J. Davis, A. S. Habib, V. D. Hooper, A. L. Kovac, P. Kranke, P. Myles, et al.
Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting
Anesth. Analg., December 1, 2007; 105(6): 1615 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
O. Sacan, P. F. White, B. Tufanogullari, and K. Klein
Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine-Glycopyrrolate and Edrophonium-Atropine
Anesth. Analg., March 1, 2007; 104(3): 569 - 574.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
S. M Wilhelm, M. L Dehoorne-Smith, and P. B Kale-Pradhan
Prevention of Postoperative Nausea and Vomiting
Ann. Pharmacother., January 1, 2007; 41(1): 68 - 78.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. J. Gan
Risk factors for postoperative nausea and vomiting.
Anesth. Analg., June 1, 2006; 102(6): 1884 - 1898.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C.-R. Cheng, D. I. Sessler, and C. C. Apfel
Does Neostigmine Administration Produce a Clinically Important Increase in Postoperative Nausea and Vomiting?
Anesth. Analg., November 1, 2005; 101(5): 1349 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. S. Murphy, J. W. Szokol, M. Franklin, J. H. Marymont, M. J. Avram, and J. S. Vender
Postanesthesia Care Unit Recovery Times and Neuromuscular Blocking Drugs: A Prospective Study of Orthopedic Surgical Patients Randomized to Receive Pancuronium or Rocuronium
Anesth. Analg., January 1, 2004; 98(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. J. Gan, T. Meyer, C. C. Apfel, F. Chung, P. J. Davis, S. Eubanks, A. Kovac, B. K. Philip, D. I. Sessler, J. Temo, et al.
Consensus Guidelines for Managing Postoperative Nausea and Vomiting
Anesth. Analg., July 1, 2003; 97(1): 62 - 71.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. T-L. Choi, S. H. Halpern, N. Malik, A. R. Jadad, M. R. Tramer, and B. Walder
Examining the Evidence in Anesthesia Literature: A Critical Appraisal of Systematic Reviews
Anesth. Analg., March 1, 2001; 92(3): 700 - 709.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.